Moleculin Biotech, Inc. Uncategorized Contracts & Agreements
16 Contracts & Agreements
- Engagement Agreement between Moleculin Biotech, Inc. and H.C. Wainwright & Co., LLC dated June 8, 2024 (Filed With SEC on August 15, 2024)
- Description of Registrant's Securities (Filed With SEC on March 24, 2022)
- Amended and Restated Sublicense Agreement dated December 20, 2021, by and between Moleculin Biotech Inc. and WPD Pharmaceuticals (Filed With SEC on December 27, 2021)
- Amended and Restated Sublicense Agreement entered into between the Company and WPD Pharmaceuticals dated March 22, 2021 (Filed With SEC on March 24, 2021)
- Description of Registrant's Securities (Filed With SEC on March 24, 2021)
- Equipment Lab Letter, dated March 16, 2020, entered into between the Company and Houston Pharmaceuticals, Inc. (HPI) (Filed With SEC on March 19, 2020)
- MATERIAL TRANSFER AGREEMENT (Filed With SEC on March 17, 2020)
- Placement Agent Agreement, dated April 23, 2019, by and between the Company and Oppenheimer & Co. Inc (Filed With SEC on April 24, 2019)
- Sublicense Agreement dated as of February 19, 2019 entered into between the Company and Animal Life Sciences, LLC (Filed With SEC on February 21, 2019)
- Sublicense Agreement dated as of February 19, 2019 entered into between the Company and WPD Pharmaceuticals (Filed With SEC on February 21, 2019)
- IndemnificationAND ADVANCEMENT Agreement (Filed With SEC on May 31, 2017)
- EMPLOYMENTAGREEMENT (Filed With SEC on August 25, 2016)
- ESCROWDEPOSIT AGREEMENT (Filed With SEC on March 22, 2016)
- IntertechBio Rights Transfer Agreement (Filed With SEC on March 22, 2016)
- AnnaMed Rights Transfer Agreement (Filed With SEC on March 22, 2016)
- ESCROWDEPOSIT AGREEMENT (Filed With SEC on February 16, 2016)
